These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6860494)

  • 1. [Interaction of the 3rd component of complement (C3) with the surface of LS murine fibroblasts].
    Melandri P; Saletti G; Benassi G
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):192-8. PubMed ID: 6860494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
    Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
    Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fixation of C3 of mice to guinea pig EAC142 complex].
    Fuks MA; da Silva NM
    An Microbiol (Rio J); 1981; 26():57-66. PubMed ID: 6982633
    [No Abstract]   [Full Text] [Related]  

  • 5. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR; De Messias-Reason IJ
    Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    Winkelstein JA; Abramovitz AS; Tomasz A
    J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
    Dieye TN; Ndiaye O; Ndiaye AB; Thiam D; Fall-Seck K; Diop S; Diop BM; Fall M; Diakhaté L
    Dakar Med; 1999; 44(2):175-9. PubMed ID: 11957280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The crucial component of the complement pathway-C3].
    Zao XZ
    Sheng Li Ke Xue Jin Zhan; 1982 Oct; 13(4):292-9. PubMed ID: 7167791
    [No Abstract]   [Full Text] [Related]  

  • 11. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV; Svehag SE; Leslie RG
    J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages.
    Riches DW; Morris CJ; Stanworth DR
    Immunology; 1982 Mar; 45(3):473-81. PubMed ID: 7037623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy.
    Cecic I; Serrano K; Gyongyossy-Issa M; Korbelik M
    Cancer Lett; 2005 Jul; 225(2):215-23. PubMed ID: 15978326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate complement pathway activation by recluse spider venom.
    Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
    Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure and functions of receptors for C3, the 3rd component of complement, present at the surface of human cells].
    Frade R
    Pathol Biol (Paris); 1985 Nov; 33(9):869-72. PubMed ID: 3909078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunofluorescence and other surface phenomena consequent to the action of immune anti-LS serums of the rabbit on LS fibroblasts].
    Melandri P; Berti G; Benassi G
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1754-9. PubMed ID: 782489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantifying components of human complement. 2. Conditions of collecting and storing sera for the determination of the C3 component. Problems in the determination of the C3 component].
    Votruba T; Rákosník P; Vancurík J; Hrudková M
    Cesk Epidemiol Mikrobiol Imunol; 1983 Sep; 32(5):259-67. PubMed ID: 6226368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.